Your browser doesn't support javascript.
loading
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
Oshima, Megumi; Neal, Bruce; Toyama, Tadashi; Ohkuma, Toshiaki; Li, Qiang; de Zeeuw, Dick; Heerspink, Hiddo J L; Mahaffey, Kenneth W; Fulcher, Gregory; Canovatchel, William; Matthews, David R; Perkovic, Vlado.
Afiliación
  • Oshima M; Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Neal B; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Toyama T; Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Ohkuma T; The Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Li Q; Imperial College London, London, United Kingdom.
  • de Zeeuw D; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Heerspink HJL; Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Mahaffey KW; Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Fulcher G; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Canovatchel W; Department of Renal and Metabolic, The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Matthews DR; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Perkovic V; Stanford University School of Medicine, Stanford, California.
J Am Soc Nephrol ; 31(10): 2446-2456, 2020 10.
Article en En | MEDLINE | ID: mdl-32694216
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Tasa de Filtración Glomerular / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Canagliflozina / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Tasa de Filtración Glomerular / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Australia